AB-ICA

• Description :

  AB-ICA is a precursor of AB-FUBICA (HY-117403) . AB-FUBICA (Compound 13) is a CB1 and CB2 receptor agonist that activates G-protein coupled inwardly rectifying potassium channels (GIRK) by binding to CB1 and CB2 receptors, displaying notable cannabinoid-like activity[1].

• UNSPSC :

  12352005

• Target :

  Drug Intermediate

• Related Pathways :

  Others

• Field of Research :

  Neurological Disease

• Smiles :

  O=C(C1=CNC2=C1C=CC=C2)N[C@@H](C(C)C)C(N)=O

• Molecular Formula :

  C14H17N3O2

• Molecular Weight :

  259.30

• References & Citations :

  [1]Banister SD, et al. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chem Neurosci. 2015 Sep 16;6 (9) :1546-59.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported